SCHEMBL14259222

SCHEMBL14259222

CCN(CC)c1nc2ccccc2cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.50
▸ PDE10A Q9Y233 1/20 0.47
▸ ALOX15 P16050 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ CREBBP Q92793 1/20 0.45
▸ ACP1 P24666 1/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ HPGD P15428 3/20 0.43
▸ GLA P06280 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ MBNL1 Q9NR56 1/20 0.42
▸ TERT O14746 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ STAT3 P40763 1/20 0.42
▸ NPY5R Q15761 1/20 0.41
▸ ELANE P08246 1/20 0.41
▸ MEN1 O00255 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19189688 0.83 ALDH1A1 (0.40) TDP1PDE10ATSHRALDH1A1HPGD
SCHEMBL12991538 0.79 TDP1 (0.55) TDP1PDE10ATSHRALDH1A1HPGD
SCHEMBL13949449 0.78 ALOX15 (0.42) ALOX15TSHRCREBBPACP1L3MBTL1
SCHEMBL13335986 0.78 SMN1; SMN2 (0.45) ALOX15TSHRCREBBPACP1L3MBTL1
SCHEMBL5910341 0.76 TDP1 (0.47) TDP1PDE10AALDH1A1HPGDGLA
SCHEMBL3197275 0.76 ACP1 (0.43) PDE10AALOX15TSHRCREBBPACP1
SCHEMBL13641185 0.75 PDE10A (0.51) TDP1PDE10AALDH1A1HPGDGLA
SCHEMBL28029896 0.74 L3MBTL1 (0.43) TDP1ALOX15TSHRCREBBPACP1
SCHEMBL7068280 0.72 TDP1 (0.55) TDP1PDE10AALDH1A1HPGDGLA
SCHEMBL23459716 0.71 KDM4E (0.41) ALOX15ACP1ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008025509-A1 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF CANCERS OF THE CENTRAL NERVOUS SYSTEM BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-06 — — WO disclosed
Send feedback